| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 514.98B | 540.95B | 539.45B | 474.77B | 396.01B |
| Gross Profit | 285.89B | 296.86B | 302.00B | 253.65B | 196.05B |
| EBITDA | 53.59B | 98.72B | 108.58B | 91.79B | 64.12B |
| Net Income | 24.03B | 7.70B | 33.95B | 25.41B | 13.46B |
Balance Sheet | |||||
| Total Assets | 868.97B | 797.57B | 765.81B | 680.33B | 597.12B |
| Cash, Cash Equivalents and Short-Term Investments | 39.86B | 41.75B | 39.21B | 36.99B | 47.30B |
| Total Debt | 236.45B | 286.84B | 277.33B | 240.60B | 234.94B |
| Total Liabilities | 637.58B | 591.91B | 604.08B | 548.71B | 498.59B |
| Stockholders Equity | 229.71B | 203.70B | 157.17B | 127.14B | 94.39B |
Cash Flow | |||||
| Free Cash Flow | 9.35B | 17.41B | 25.43B | 43.55B | 37.09B |
| Operating Cash Flow | 25.98B | 44.58B | 51.61B | 69.75B | 49.73B |
| Investing Cash Flow | -11.21B | -38.20B | -36.73B | -44.87B | -19.38B |
| Financing Cash Flow | -20.36B | -5.66B | -16.37B | -38.98B | -18.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥152.56B | 7.03 | ― | 2.33% | 25.95% | 66.92% | |
74 Outperform | ¥82.19B | 7.58 | ― | 3.85% | 9.38% | 8.88% | |
72 Outperform | ¥75.83B | 7.91 | 6.66% | 3.36% | 3.80% | -15.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.68B | -14.04 | ― | 2.05% | -6.69% | -80.28% | |
62 Neutral | ¥109.76B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% | |
57 Neutral | ¥337.11B | 15.50 | 11.46% | 3.77% | -9.34% | 164.21% |